Therefore, the present study investigated whether miR-30a regulates immune and islet cell inflammation and function by targeting IL-1α and found that 30a serves as a promising buffer and response factor in inflammatory diseases including diabetes. This evidence concerns the gene IL1A and diabetes mellitus.